Christopher D Giedt, MD in Port Townsend, WA - Hospitalist

Christopher D Giedt, MD is a Hospitalist physician based in Port Townsend, Washington. Christopher D Giedt is licensed to practice in Washington (license number MD60139981) and his current practice location is 834 Sheridan St, Port Townsend, Washington. He can be reached at his office (for appointments etc.) via phone at (360) 385-2200.

NPI number for Christopher D Giedt is 1700053667 and his current mailing address is 834 Sheridan St, Port Townsend, Washington. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1700053667.

Contact Information

	Christopher D Giedt, MD
	834 Sheridan St, Port Townsend, WA 98368-2443
	(360) 385-2200
	Not Available

Physician's Profile

Full Name	Christopher D Giedt
Gender	Male
Speciality	Hospitalist
Location	834 Sheridan St, Port Townsend, Washington
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1700053667
Provider Enumeration Date: 05/09/2008
Last Update Date: 01/28/2011

Medical Identifiers

Medical identifiers for Christopher D Giedt such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1700053667	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208M00000X	Hospitalist	MD60139981 (Washington)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Christopher D Giedt is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Christopher D Giedt, MD 834 Sheridan St, Port Townsend, WA 98368-2443 Ph: (360) 385-2200	Christopher D Giedt, MD 834 Sheridan St, Port Townsend, WA 98368-2443 Ph: (360) 385-2200

News Archive

China with the world: COVID-19 experts dialogues - the 2nd talk transcript

Q: Starting from the patient admission to the hospital, what is your rule for ventilation? Do you start from HFNC, CPAP, NIV or go directly to intubation and invasive ventilation when the conventional oxygen therapy fails?

Caliper Life Sciences to use SRU Biosystems' label-free BIND technology for new functional assays

SRU Biosystems today announced that Caliper Life Sciences will use SRU Biosystems' label-free BIND® technology to offer new functional assays as part of its Discovery Alliances and Services.

Immunotherapy maintenance shows promise in NSCLC

Results from a phase III trial have shown that tecemotide is no more effective than placebo as maintenance therapy in patients with non-small-cell lung cancer.

Discovery of new genetic clues to breast cancer

Researchers at Cambridge University have identified five genetic clues for women who have a family history of breast cancer. The study brings up the number of common genetic variations linked to increased risk of breast cancer in women to 18. The study was published in Nature Genetics.

Christopher D Giedt, MD - Hospitalist in Port Townsend, WA